Lifecare AS
OSE:LIFE
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
12.6
55.8363
|
| Price Target |
|
We'll email you a reminder when the closing price reaches NOK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Lifecare AS
Lifecare AS
Total Equity
Lifecare AS
Total Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Lifecare AS
OSE:LIFE
|
Total Equity
kr66.4m
|
CAGR 3-Years
71%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Medistim ASA
OSE:MEDI
|
Total Equity
kr383.3m
|
CAGR 3-Years
14%
|
CAGR 5-Years
14%
|
CAGR 10-Years
12%
|
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Total Equity
kr115.6m
|
CAGR 3-Years
78%
|
CAGR 5-Years
47%
|
CAGR 10-Years
N/A
|
|
Lifecare AS
Glance View
Lifecare AS engages in the research, testing, and development of medical sensors for health monitoring. The company is headquartered in Bergen, Hordaland. The company went IPO on 2018-07-10. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.
See Also
What is Lifecare AS's Total Equity?
Total Equity
66.4m
NOK
Based on the financial report for Dec 31, 2023, Lifecare AS's Total Equity amounts to 66.4m NOK.
What is Lifecare AS's Total Equity growth rate?
Total Equity CAGR 5Y
24%
Over the last year, the Total Equity growth was 18%. The average annual Total Equity growth rates for Lifecare AS have been 71% over the past three years , 24% over the past five years .
You don't have any saved screeners yet
